跳到正文
cccskills

“screen”的搜索结果

3020 个 · 按相关度排序

HTML -> UCUF (Cocos Creator UI) conversion skill. Use for turning a complete HTML source package with ui-design-tokens.json and colors_and_type.css into Cocos usable layout/skin/screen JSON, then validating with Plan5 final fidelity gates: stale-rule audit, rule guard, visual fidelity risk, runtime interaction smoke, Cocos Editor final gate, and 95% regression matrix.

中文简介正在准备中。当前显示原文说明。

eaglhuang/3klife32026年10月21日 更新

DEBUGGING SKILL — Read and analyze Cocos Creator project.log for runtime errors, warnings, and stack traces. USE FOR: any bug report, crash, UI glitch, TypeError, null reference, missing asset, CompositePanel mount fail, ChildPanel route fail, or screen spec wiring error. Load this skill FIRST before any runtime debugging session. DO NOT USE FOR: compile errors (use get_errors tool instead).

中文简介正在准备中。当前显示原文说明。

eaglhuang/3klife32026年10月21日 更新

BROWSER VFX ACCEPTANCE SKILL — Use built-in browser/headless browser to automatically verify Cocos VFX block effects and composed VFX recipes in BattleScene preview (`http://localhost:7456`, `previewMode=true`, `previewTarget=5`). USE FOR: VFX health audit, per-block smoke validation, combo recipe regression checks before merging `vfx-block-registry.ts` / `vfx-effects.json`. DO NOT USE FOR: Cocos Editor window screenshot capture, compile-error debugging, or pure log-only diagnosis without browser preview.

中文简介正在准备中。当前显示原文说明。

eaglhuang/3klife32026年10月21日 更新

UI 資產品質驗證 SKILL — 執行 validate-visual-assets.js、validate-ui-specs.js 與必要的 snapshot regression,對 skin family 資產、screen package、proof draft / family-map 進行全面驗證,並回寫 generated-review。USE FOR: 任何 UI 資產生成後、在 ui-preview-judge 前必須先通過的 QA 關卡。DO NOT USE FOR: debug runtime 崩潰(用 cocos-log-reader)、Layout 佈局調整(用 ui-vibe-pipeline)。

中文简介正在准备中。当前显示原文说明。

eaglhuang/3klife32026年10月21日 更新

Review a built frontend against its chosen direction, catch drift back to generic AI defaults, enforce state coverage, ethical patterns, UX heuristics, and polish, and check contrast with APCA (not the legacy WCAG ratio). Produces specific, prioritized fixes — never vibes-based feedback. Works with pasted screenshots or Playwright MCP automated capture. Load when the user asks to review a UI, audit a design, check if a frontend looks generic or vibecoded, evaluate visual quality or polish, says "review this UI", "is this design good", "audit my frontend", "does this feel like [product]", "design QA", or when frontend-design routes here. Sub-skill of frontend-design.

中文简介正在准备中。当前显示原文说明。

dvy1987/agent-loom32026年8月8日 更新

flow

免费

Verify a code change end-to-end in the current worktree: identify what changed, run the relevant tests, get the app running, drive a browser over the affected areas, and report a verdict with screenshots. Generic across project types (Laravel/Herd, Node/bun, frontend, CLI, library). Use when the user wants to verify/QA/smoke-test a change, check that a PR or branch works, validate uncommitted work, or says "/flow", "verify this change", "does this PR work", "test and click through this". Optional target: PR number/URL, branch/ref, or worktree path; default is the current working changes.

中文简介正在准备中。当前显示原文说明。

samuelpatro/.claude32026年9月3日 更新

Implement several variations of a design directly inside the running app, on the real page/route, with a live switcher to toggle between them in the browser, then recommend one and fold the winner into the real code. Variants are real implementations judged against real data, layout, and density (not an isolated mockup). Use this skill whenever the user wants to try design options live in the app, prototype changes directly on a real page, add a variant switcher, compare layouts in-context, asks to "build a few versions of this page", "try variants on the real screen", "switch between designs in the app", "implement this with a toggle", or says "real-prototype this". For a safe standalone .html copy that never touches the app, use the prototype skill instead.

中文简介正在准备中。当前显示原文说明。

samuelpatro/.claude32026年9月3日 更新

findmy

免费

Track Apple devices and AirTags via FindMy.app on macOS using AppleScript and screen capture.

中文简介正在准备中。当前显示原文说明。

q2805187159/Anvil32026年6月24日 更新

Toolkit for interacting with and testing local web applications using Playwright. Supports verifying frontend functionality, debugging UI behavior, capturing browser screenshots, and viewing browser logs.

中文简介正在准备中。当前显示原文说明。

q2805187159/Anvil32026年6月24日 更新

Improves the quality of images, especially screenshots, by enhancing resolution, sharpness, and clarity. Perfect for preparing images for presentations, documentation, or social media posts.

中文简介正在准备中。当前显示原文说明。

q2805187159/Anvil32026年6月24日 更新

Tests whether two genomic interval sets overlap (colocalize) more than expected by chance using a permutation test against a structured-genome null model. Covers bedtools fisher (analytic 2x2 screen), bedtools shuffle + jaccard permutation, GAT (isochore/GC-conditioned simulation with FDR), regioneR (flexible permutation, randomizeRegions vs circularRandomizeRegions, localZScore), LOLA (universe-relative Fisher against a region database), and GREAT/rGREAT (regulatory-domain binomial + hypergeometric for ontology-from-regions). Stresses the universe/background choice, matched background, blacklist exclusion, and multiple-testing control. Use when asking whether peaks/regions are enriched at enhancers/TFBS/features, scoring region-set colocalization or region-set enrichment, comparing CNV/SV concordance, or turning an overlap count into a defensible p-value.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Detects m6A modifications from Oxford Nanopore direct-RNA-sequencing (ONT DRS) signal data using m6Anet (Hendra 2022 *Nat Methods* 19:1590; multiple-instance-learning neural network over DRACH 5-mer signal). Covers the required upstream pipeline (Dorado / Guppy basecalling -> minimap2 transcriptome alignment with `-ax map-ont -uf -k14 --secondary=no` -> nanopolish eventalign with `--scale-events --signal-index` (m6Anet-required) plus `--summary` / `--threads` housekeeping -> m6anet dataprep -> m6anet inference), per-site vs per-read probability interpretation including the `mod_ratio` per-site stoichiometry column, the DRACH-only modeling constraint, minimum-coverage thresholds (20-50 reads per site for stable probability estimates), multi-condition comparison via xPore (Pratanwanich 2021 *Nat Biotechnol* 39:1394), Nanocompore (Leger 2021 *Nat Commun* 12:7198), ELIGOS (Jenjaroenpun 2021 *NAR* 49:e7), and Dorado native modification calling (RNA004 chemistry, 2024+), reference-transcriptome version pinning, the cDNA-vs-DRS chemistry distinction (cDNA-Nanopore CANNOT be used for modification detection), and orthogonal validation against MeRIP / GLORI. Use when calling m6A from ONT DRS without immunoprecipitation, choosing m6Anet vs xPore vs Nanocompore vs ELIGOS vs Dorado native, interpreting per-site `probability_modified` vs `mod_ratio` vs per-read modification probabilities, comparing methylation between conditions from ONT data, deciding between m6Anet for known DRACH sites and Dorado/Remora for genome-wide screening, pinning RNA002 vs RNA004 chemistry and basecaller model versions, or troubleshooting eventalign / dataprep failures.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Processes eDNA metabarcoding from raw paired-end reads to species tables, navigating ASV (DADA2, UNOISE3) vs OTU (swarm v2) decision (Callahan 2017 vs Schloss multi-copy-16S critique), marker/primer choice (Leray COI, MiFish 12S, 515F/806R 16S, ITS2) with primer-specific bias, OBITools3 v3 command-name break (obi stats plural; .tar.gz taxonomy), tag-jumping with dual-indexing (Schnell 2015; NovaSeq 10x MiSeq), decontam as screening-not-classifier (Davis 2018), read-counts-not-abundance critique (Lamb 2019), site-occupancy modeling (Ficetola 2015), Naive-Bayes calibration limits (Bokulich 2018), and eDNA decay (Strickler 2015). Use when going from raw eDNA FASTQ to species tables, picking marker + denoising pipeline, deciding whether read counts represent abundance, applying occupancy modeling, configuring OBITools3 v3, or interpreting decontam output. Not for clinical 16S microbiome (see microbiome/amplicon-processing).

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Detects acquired antimicrobial-resistance determinants and chromosomal point-mutation resistance in bacterial assemblies using AMRFinderPlus, ResFinder 4.0 (acquired + PointFinder), CARD-RGI, abritAMR, staramr, and species-specific callers (TB-Profiler, Mykrobe). Harmonises cross-tool output via hAMRonization, contextualises determinants with mobile-genetic-element annotation (MOB-suite, PlasmidFinder, MobileElementFinder, ICEberg), predicts phenotype against EUCAST or CLSI breakpoints, and translates calls into WHO GLASS reporting categories. Use when screening clinical or surveillance isolates for AMR, distinguishing acquired vs intrinsic vs point-mutation resistance, calling rpoB / katG / pncA / gyrA / mgrB mutations, reconciling AMRFinderPlus vs RGI vs ResFinder disagreement, contextualising carbapenemases or mcr alleles on plasmids, predicting susceptibility from genotype against the WHO Mtb 2nd-edition catalogue, or building a hAMRonized multi-lab AMR surveillance pipeline.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Build genome-browser-style multi-track figures with pyGenomeTracks (config-driven), Gviz (R), and IGV batch screenshotting. Covers BigWig coverage tracks, BED/peak overlays, gene-model rendering, Hi-C matrix tracks, BedPE link arcs, spike-in-aware normalization, and the bamCoverage --normalizeUsing trap. Use when producing publication figures of genomic loci with stacked aligned tracks (coverage, peaks, genes, interactions) for ChIP-seq, ATAC-seq, RNA-seq, Hi-C, or generic locus visualization.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Calls HLA class I and class II alleles at 2/4/6/8-field resolution from WGS/WES/RNA-seq/long-read data using OptiType, HLA-LA, T1K, Polysolver, HLA-HD, arcasHLA, StarPhase, or HIBAG imputation. Use when typing for HSCT, solid-organ transplant, neoantigen prediction, PGx screening (B*57:01, B*15:02, etc.), or disease-association studies, with reconciliation across tools and IPD-IMGT/HLA version mismatch handling.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Calls microsatellite instability from WES/WGS/targeted-panel with MSIsensor, MSIsensor-pro, MSIsensor-ct (panel-aware), MSIngs, MANTIS, MSIPanel, MSIDetect, and ngsMSI for FDA pembrolizumab MSI-H pan-tumor / Lynch syndrome / dMMR ICI biomarker. Use when stratifying ICI eligibility (Le 2015), pairing MSI with TMB-H (Sha 2020 / Salem 2018), screening Lynch syndrome (universal IHC + MSI), or distinguishing MSI-H tumors from POLE-exo hypermutator with overlapping signatures.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Prioritizes rare-disease variants from trio/quad WES/WGS with de novo (DeNovoGear, Triodenovo), compound-heterozygous phasing (WhatsHap), mosaic VAF tiering, phenotype-driven ranking (Exomiser, Phen2Gene, AMELIE), ClinGen gene-disease validity gating, and ACMG SF v3.2 secondary findings reporting. Use when running diagnostic exome / genome pipelines, identifying candidate Mendelian disease genes, screening for incidental findings, or auditing VUS reclassification cycles. The ACMG/AMP classification framework (PVS1 decision tree, Pejaver PP3/BP4 calibration, Tavtigian point system) is in clinical-databases/acmg-classification.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Queries PharmGKB / CPIC / DPWG for drug-gene interactions; calls CYP2D6/CYP2C9/CYP2C19/DPYD/TPMT/NUDT15/UGT1A1/SLCO1B1 star alleles and phenotype with PharmCAT, Cyrius (CYP2D6 structural variants), Aldy, Stargazer; applies Caudle 2020 activity-score translation. Use when implementing pharmacogenomic-guided prescribing, applying CPIC vs DPWG guidance, screening HLA risk alleles for ICI / antiepileptics / abacavir, or interpreting compound TPMT+NUDT15 thiopurine risk.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Detect horizontal gene transfer (HGT / LGT) using compositional methods (GC%, codon usage, tetranucleotide z-scores via SIGI-HMM, AlienHunter, IslandViewer 4, IslandPath-DIMOB), phylogenetic-incongruence methods (AvP, HGTphyloDetect, ALE / GeneRax / AleRax reconciliation, RANGER-DTL), and BLAST-distribution methods (HGTector v2, DarkHorse, Alien Index). Use when screening prokaryote genomes for genomic islands and HGT events, distinguishing HGT from incomplete lineage sorting / differential gene loss / hybridization, mapping donor lineages via phylogenetic placement, separating eukaryotic HGT from contamination, ruling out gBGC as a false signal, or quantifying DTL rates with ALE/GeneRax on bacterial trees.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Detect positive (diversifying / episodic / pervasive) selection using codon dN/dS frameworks. Implements PAML codeml site models (M0/M1a/M2a/M7/M8/M8a), branch models, branch-site model A (Zhang 2005), and HyPhy methods (BUSTED, BUSTED-S, BUSTED-MH, BUSTED-PH, MEME, FEL, FUBAR, aBSREL, SLAC, RELAX, GARD, FUBAR-MH). Includes McDonald-Kreitman framework (asymptotic alpha, impMKT, polyDFE, DFE-alpha, GRAPES) for within-species + divergence inference, RERconverge for trait-correlated rate shifts, CSUBST for convergent substitution, and PhyloAcc for accelerated noncoding evolution. Use when testing adaptive evolution at codons, branches, or full gene; running GARD recombination pre-screen; controlling alignment-error and gBGC false positives; reconciling PAML vs HyPhy results; or performing genome-scale selection scans.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Compute genome-to-genome distances (ANI, AAI, dDDH, k-mer Mash) and assign taxonomic classifications using skani (Shaw 2023), FastANI (Jain 2018), pyani / pyANI ANIb / ANIm, OrthoANI (Lee 2016), AAI (amino-acid identity), dDDH via TYGS / GGDC, GTDB-Tk (Chaumeil 2020 standard prokaryote taxonomy), and Mash MinHash (Ondov 2016). Use when delineating prokaryote species (95% ANI threshold; Jain 2018 Nat Commun 9:5114), assigning genomes to GTDB taxonomy with ANI radius, computing genome similarity matrices for clustering, classifying archaea, evaluating MAG (metagenome-assembled genome) species assignment, applying skani for fast metagenomic ANI screening, or reconciling 16S rRNA-based taxonomy with whole-genome ANI.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新

Calculates molecular fingerprints (ECFP/Morgan, FCFP, MACCS, RDKit, AtomPair, TopologicalTorsion, Avalon, MAP4, MHFP6) and physicochemical descriptors (Lipinski, QED, TPSA, Crippen LogP, 3D shape) with explicit choice tables, bit vs count semantics, and partial-charge model selection. Use when featurizing molecules for similarity, QSAR, virtual screening, or ML, or selecting the correct fingerprint for a chemotype-aware task.

中文简介正在准备中。当前显示原文说明。

peacezha/HPClaw32026年10月11日 更新